Drug
Tolterodine clinical trials
Also written Detrol.
- studies test it
- 48
- open now
- 3
- in phase 3
- 8
- first study started
- 2003
Keep track of what changes. Save the tolterodine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
48 studies that test it; most in 2009 (7)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 6
- Phase 3
- 8
- Phase 4
- 23
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 26
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (10) · Astellas Pharma Inc (3) · Merck Sharp & Dohme LLC (3) · Far Eastern Memorial Hospital (3) · Samsung Medical Center (2) · Buddhist Tzu Chi General Hospital (2) · Kasr El Aini Hospital (1) · Yuzuncu Yil University (1)
Often tested with
Tested in the same studies.
Mirabegron (6) · Solifenacin (3) · Oxybutynin (2) · Doxazosin (2) · Vibegron (2) · Tadalafil (1) · Estradiol (1) · Pilocarpine (1)
Studies
Open first, then newest update. How each study uses tolterodine is read from its arms, and is right about nine times in ten.
Testing it · 48
- TReating Incontinence for Underlying Mental and Physical HealthRecruitingPhase 4University of California, San FranciscoNCT05362292Written as Tolterodine Tartrate ER
- The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingPhase 3Far Eastern Memorial HospitalNCT07114640Written as Tolterodine 4 mg
- Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled StudyRecruitingPhase 4Far Eastern Memorial HospitalNCT05946902Written as tolterodine
- A Study of YM178 in Subjects With Symptoms of Overactive BladderCompletedPhase 3Astellas Pharma IncNCT01043666Written as tolterodine ER
- Pharmacological vs Surgical Treatment for Mixed IncontinenceWithdrawnPhase 4Imperial College LondonNCT00523068Written as Tolterodine
- Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.CompletedPhase 1Kasr El Aini HospitalNCT04500860Written as Tolterodine 4 Mg Oral Capsule, Extended Release
- Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea SyndromeCompletedPhase 4Yuzuncu Yil UniversityNCT05250245Written as Tolterodine Tartrate 4 MG
- Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive BladderTerminatedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01302938Written as Tolterodine ER
- Pharmacokinetics and Relative Bioavailability StudyCompletedPhase 1Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01521767Written as tolterodine tartrate
- Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.CompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00230789Written as Tolterodine ER 4 mg QD
- A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.CompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00645281Written as tolterodine extended release
- Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in WomenCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00143481Written as Tolterodine ER 4mg QD
- Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release TabletCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00139724Written as tolterodine extended release capsule
- Detrol LA In Men With Overactive Bladder.CompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00282932Written as Detrol LA
- Effects Of Detrol LA On Memory And Cognition In Elderly PopulationCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00411437Written as Tolterodine ER
- A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive BladderCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00137397Written as Tolterodine ER
- Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.CompletedPhase 1Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00481728Written as Tolterodine
- Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After SurgeryStatus unknownNot applicableXuanwu Hospital, BeijingNCT03280316Written as M receptor antagonist
- A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)CompletedPhase 4Astellas Pharma Global Development, Inc.NCT02138747Written as Tolterodine ER
- Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) PatientsCompletedPhase 4KYU-SUNG LEENCT00730535Written as Tolterodine
See all 48 studies that test tolterodine →
Given in every arm · 5 — tolterodine is usual care beside what is tested
- Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.CompletedPhase 4Astellas Pharma IncNCT02294396Written as Tolterodine capsule
- Genetic Determinants of Amitriptyline Efficiency for Pain TreatmentCompletedPhase 4Insel Gruppe AG, University Hospital BernNCT02256943Written as Tolterodine
- Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part IICompletedPhase 4Insel Gruppe AG, University Hospital BernNCT02256956Written as Tolterodine
- Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in WomenCompletedPhase 2Ferring PharmaceuticalsNCT01729819Written as Tolterodine tartrate extended release capsules
- Behavior Enhances Drug Reduction of Incontinence (BE-DRI)CompletedNot applicableCarelon ResearchNCT00090584Written as Tolterodine
As the comparator · 23 — what is tested is compared with tolterodine
- Non-invasive Saphenous Nerve Stimulation Therapy for Overactive BladderNot yet recruitingPhase 3NinaMED Pty LtdNCT07780786Written as tolterodine tartrate 4 mg extended release
- Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderCompletedPhase 3Astellas Pharma IncNCT00689104Written as Tolterodine
- Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderCompletedPhase 3Astellas Pharma IncNCT00688688Written as Tolterodine
- A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive BladderCompletedPhase 3Astellas Pharma IncNCT00966004Written as tolterodine
- Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive BladderCompletedPhase 2Astellas Pharma Europe B.V.NCT01604928Written as tolterodine
- Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive BladderStatus unknownPhase 4China Medical University HospitalNCT04909255Written as oxybutynin, tolterodine, solifenacin
- An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).CompletedPhase 3Urovant Sciences GmbHNCT03583372Written as Tolterodine Tartrate ER
- A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)CompletedPhase 3Urovant Sciences GmbHNCT03492281Written as Tolterodine Tartrate ER
- Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.CompletedPhase 3R-PharmNCT03575702Written as Urotol®
- Treatment of Incontinence Without Memory ProblemsCompletedPhase 4University of California, San FranciscoNCT02436889Written as Tolterodine Tartrate
- Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in WomenCompletedNot applicableShanghai Institute of Acupuncture, Moxibustion and MeridianNCT02723279Written as TT
- Combined Behavioral and Drug Treatment of Overactive Bladder in MenCompletedPhase 2/3University of Alabama at BirminghamNCT01175382Written as Tolterodine + tamsulosin
- Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OABCompletedPhase 3SK Chemicals Co., Ltd.NCT02485067Written as Detrusitol 2mg tablet
- SSR240600C Treatment in Women With Overactive BladderCompletedPhase 2SanofiNCT00564226Written as tolterodine
- Study of Herbmed Plus in Ureteral Stent DiscomfortCompletedPhase 2Dr .S.B.PATANKARNCT01356355Written as Tolterodine
- Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)CompletedPhase 3PfizerNCT00444925Written as tolterodine tartrate
- Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy SubjectsCompletedPhase 1NovartisNCT00703703Written as Tolterodine
- Study of ONO-8539 in Patients With Overactive BladderCompletedPhase 2Ono Pharmaceutical Co. LtdNCT00876421Written as Tolterodine
- MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.CompletedPhase 2SanofiNCT00174798Written as Tolterodine
- Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.CompletedPhase 3PfizerNCT00611026Written as Tolterodine ER
Showing 20 of 23.
Codes
What other systems call tolterodine · ClinicalTrials.gg INT006535
- MeSH (NLM) D000068737Tolterodine TartrateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WHE7A56U7KTOLTERODINEConfirmed FDA, NLM, Wikidata
- RxNorm 119565Confirmed FDA, Wikidata
- Wikidata Q424312tolterodineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62083TolterodineOne source FDA
- DrugBank DB01036One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068737 | Tolterodine Tartrate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WHE7A56U7K | TOLTERODINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 119565 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424312 | tolterodine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62083 | Tolterodine | One source FDA |
| DrugBank | DB01036 | — | One source Wikidata |
Also registered as tolterodine tartrate (UNII 5T619TQR3R · RxNorm 221174).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.